REG3A and type 2 diabetes mellitus: Most importantly, in the patients with obesity and T2D, we observed significantly reduced Reg3α expression, together with evidence of attenuated intestinal AMPK T172 phosphorylation suggestive of its activity (Fig. 3i, j).